Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.
- 1 October 2000
- journal article
- case report
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 73 (874) , 1112-1114
- https://doi.org/10.1259/bjr.73.874.11271907
Abstract
Haemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported.Keywords
This publication has 5 references indexed in Scilit:
- High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.Journal of Clinical Oncology, 1996
- High-Dose Chemotherapy for Resistant Germ Cell Tumors: Recent Advances and Future DirectionsJNCI Journal of the National Cancer Institute, 1992
- Cyclophosphamide-induced cardiomyopathy. A report of two cases and review of the english literatureCancer, 1979
- ACUTE LETHAL CARDITIS CAUSED BY HIGH-DOSE COMBINATION CHEMOTHERAPYThe Lancet, 1976